Translations:Diabetic nephropathy/30/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
Tags: Mobile edit Mobile web edit
 
(No difference)

Latest revision as of 00:30, 27 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Diabetic nephropathy)
== Further reading ==
{{refbegin|32em}}
* {{Cite web|title = Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis|url = http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?AccessionNumber=12009100199|website = www.crd.york.ac.uk|access-date = 2015-07-02}}
* {{cite journal | vauthors = Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T | title = Diabetic nephropathy: diagnosis, prevention, and treatment | journal = Diabetes Care | volume = 28 | issue = 1 | pages = 164–76 | date = January 2005 | pmid = 15616252 | doi = 10.2337/diacare.28.1.164 | doi-access = free }}
* {{cite journal | vauthors = Tziomalos K, Athyros VG | title = Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis | journal = The Review of Diabetic Studies | volume = 12 | issue = 1–2 | pages = 110–8 | year = 2015 | pmid = 26676664 | pmc = 5397986 | doi = 10.1900/RDS.2015.12.110 }}
* {{cite journal | vauthors = Kume S, Koya D, Uzu T, Maegawa H | title = Role of nutrient-sensing signals in the pathogenesis of diabetic nephropathy | journal = BioMed Research International | volume = 2014 | pages = 315494 | date = 2014 | pmid = 25126552 | pmc = 4122096 | doi = 10.1155/2014/315494 | doi-access = free }}
* {{cite journal | vauthors = Doshi SM, Friedman AN | title = Diagnosis and Management of Type 2 Diabetic Kidney Disease | journal = Clinical Journal of the American Society of Nephrology | volume = 12 | issue = 8 | pages = 1366–1373 | date = August 2017 | pmid = 28280116 | pmc = 5544517 | doi = 10.2215/CJN.11111016  }}
{{refend}}

Further reading

  • "Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis". www.crd.york.ac.uk. Retrieved 2015-07-02.
  • Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (January 2005). "Diabetic nephropathy: diagnosis, prevention, and treatment". Diabetes Care. 28 (1): 164–76. doi:10.2337/diacare.28.1.164. PMID 15616252.
  • Tziomalos K, Athyros VG (2015). "Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis". The Review of Diabetic Studies. 12 (1–2): 110–8. doi:10.1900/RDS.2015.12.110. PMC 5397986. PMID 26676664.
  • Kume S, Koya D, Uzu T, Maegawa H (2014). "Role of nutrient-sensing signals in the pathogenesis of diabetic nephropathy". BioMed Research International. 2014: 315494. doi:10.1155/2014/315494. PMC 4122096. PMID 25126552.
  • Doshi SM, Friedman AN (August 2017). "Diagnosis and Management of Type 2 Diabetic Kidney Disease". Clinical Journal of the American Society of Nephrology. 12 (8): 1366–1373. doi:10.2215/CJN.11111016. PMC 5544517. PMID 28280116.
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Diabetic_nephropathy/30/en&oldid=121635"